So, who exactly, is 'insinuating' that FDA approval is just around the corner. Or have you invented that for your own purposes?
Plus, who don't you present an informed analysis of the recent experience with Orphan drug approval timelines - something useful - rather than just plucking irrelevant comparisons out of the air. Shouldn't be too difficult.
DXB Chart, page-1060
-
- There are more pages in this discussion • 350 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.025(6.17%) |
Mkt cap ! $214.4M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 40.5¢ | 38.0¢ | $1.090M | 2.806M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 704 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 60907 | 1 |
View Market Depth
| Last trade - 15.58pm 18/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |